Home

Dyskeratosis congenita telomere

Telomer bei Amazon.d

  1. Die besten Bücher bei Amazon.de. Kostenlose Lieferung möglic
  2. Dyskeratosis congenita orsakas av en defekt i underhållet av kromosomändarna (telomererna). Begreppet telomer kommer av grekiskans telos = ände och meros = del. Telomererna fungerar som ett skydd för nedbrytning av kromosomerna
  3. Dyskeratosis congenita is a disorder of poor telomere maintenance mainly due to a number of gene mutations that give rise to abnormal ribosome function, termed ribosomopathy. Specifically, the disease is related to one or more mutations which directly or indirectly affect the vertebrate telomerase RNA component (TERC)
  4. Telomere Syndromes and Dyskeratosis Congenita Telomere syndromes are inherited conditions that can cause bone marrow failure and lung disease. These syndromes vary in severity and can affect children and adults. In rare cases, a patient's telomere syndrome may appear as a condition called dyskeratosis congenita
  5. Clinical characteristics: Dyskeratosis congenita (DC), a telomere biology disorder, is characterized by a classic triad of dysplastic nails, lacy reticular pigmentation of the upper chest and/or neck, and oral leukoplakia. The classic triad may not be present in all individuals
  6. Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized by cutaneous symptoms, including hyperpigmentation and nail dystrophy. Some forms of DC are caused by mutations in telomerase, the enzyme that counteracts telomere shortening, suggesting a telomere-based disease mechanism

Dyskeratosis congenita - Socialstyrelse

  1. Dyskeratosis congenita (DC) is a cancer-prone inherited bone marrow failure syndrome caused by aberrant telomere biology. The mucocutaneous triad of nail dysplasia, abnormal skin pigmentation and oral leukoplakia is diagnostic, but is not always present; DC can also be diagnosed by the presence of very short leukocyte telomeres
  2. The genes that are mutated in dyskeratosis congenita are all in one way or the other important for the telomerase enzyme to do its job or for the telomere end to be available for the enzyme. Mutations in these genes jeopardize the activity of the enzyme at the end of telomeres
  3. Dyskeratosis Congenita (DC) is an inherited bone marrow failure syndrome that develops as a result of defective telomere maintenance, it is therefore categorized as a telomere biology disorder (TBD). The clinical sensitivity and specificity for Flow FISH telomere length analysis have been defined for the diagnosis of DC

A Community of Telomere Biology Disorders. Our mission is to provide information and support services to families worldwide affected by Dyskeratosis Congenita and Telomere Biology Disorders, to encourage the medical community's research in finding causes and effective treatments, and to facilitate improved diagnosis by educating medical providers The X-linked form of the human disease dyskeratosis congenita (DKC) is caused by mutations in the gene encoding dyskerin 1. Sufferers have defects in highly regenerative tissues such as skin and.. Causes. Expand Section. In about half of people with dyskeratosis congenita, the disorder is caused by mutations in the TERT, TERC, DKC1, or TINF2 gene. These genes provide instructions for making proteins that help maintain structures known as telomeres, which are found at the ends of chromosomes

Dyskeratosis congenita - Wikipedi

Dyskeratosis congenita (DC) is a rare condition classified under a broad spectrum of genetic disorders known as telomere diseases. These diseases can often cause bone marrow failure and lung disease. People with DC frequently develop unusual skin pigmentation patterns, nail discoloration, white patches in the mouth (oral leukoplakia) and are. Introduction. Dyskeratosis congenita (DC) is a debilitating disorder caused primarily by mutations in the DKC1 gene that encodes DYSKERIN, a protein critical for telomerase complex function, leading to failures in telomere maintenance (Armanios and Blackburn, 2012, Savage, 2014).In the context of DC, telomere defects manifest in highly proliferative tissues that normally require telomerase in.

Dyskeratosis congenita (DC) is an inherited disorder characterized by bone marrow failure, cancer predisposition, and additional somatic abnormalities Dyskeratosis congenita, a disease characterized by defective maintenance of blood, pulmonary and epidermal tissues, is caused by defects in genes required for telomere homeostasis. Short telomeres.

Dyskeratosis congenita (DC) was the first TBD to be described. The subsets of DC include classic DC, Hoyeraal Hreidarsson syndrome (HHS), Revesz syndrome, DC-like conditions and isolated subtypes. Patients with the classic forms of DC are usually diagnosed in childhood, and they have a triad of mucocutaneous features including dysplastic nails, anomalies of skin pigmentation, and oral leukoplakia Dyskeratosis congenita (DC), the prototypical TBD, is an inherited bone marrow failure syndrome caused by defects in the telomere maintenance pathway Dyskeratosis congenita is the prototype of telomere diseases; it is characterized by bone marrow failure, mucocutaneous abnormalities, pulmonary fibrosis, liver cirrhosis, and increased susceptibility to cancer, including acute myeloid leukemia 1. Dyskeratosis congenita. First described as a discrete syndrome in 1910 , dyskeratosis congenita (DC) is a disease that can be pigeon-holed into a number of alternative classifications including premature aging syndrome, bone marrow failure syndrome and cancer predisposition syndrome, amongst others.In truth, DC is a highly heterogeneous disorder that is difficult to. Subscribe: https://tinyurl.com/medxclusiveSUBBlog: https://medXclusive.orgMCAT Blog: https://mcatxclusive.com/Any Video Clips Used -- are used with the Per..

Team Telomere | A Community for Telomere Biology Disorders. Dyskeratosis congenita (DKC), also known as Zinsser-Engman-Cole syndrome, is a rare, progressive bone marrow failure syndrome characterized by the triad of reticulated skin hyperpigmentation, nail dystrophy, and oral leukoplakia. Evidence exists for telomerase dysfunction, ribosome deficiency, and protein synthesis dysfunction in this disorder Our mission is to provide information and support services to families worldwide affected by Dyskeratosis Congenita and Telomere Biology Disorders, to encourag Team Telomere January 28 at 11:30 AM dyskeratosis congenita A rare genetic disorder characterized by nail dystrophy, reticulated skin pigmentation especially on the neck and chest, and oral leukoplakia. Mutations in the TERT, TERC, DKC1, or TINF2 genes are identified

Dyskeratosis congenita. More than 40 mutations in the DKC1 gene have been identified in people with dyskeratosis congenita. This disorder is characterized by changes in skin coloring (pigmentation), white patches inside the mouth (oral leukoplakia), and abnormally formed fingernails and toenails (nail dystrophy) Dyskeratosis congenita. Mason is rare — as his mom duly noted — because he was born with dyskeratosis congenita (DC), a progressive condition that is believed to affect only one person in 1 million.It is both predictable in that its most common manifestation is bone marrow failure and unpredictable in that no two patients are symptomatically alike

Telomere Syndromes and Dyskeratosis Congenita: Johns

Brad in October 2018, a year before he died from dyskeratosis congenita. Brad's cells live on in the lab, and have helped provide clues to new treatments for his condition and other telomere diseases. (Family photos courtesy of Garrett Martin. therefore that dyskeratosis congenita may primarily be a disor-der of telomere maintenance. The most compelling evidence supporting this view is that autosomal dominant dyskeratosis congenita can result from TERC mutations (18), which cause a reduction in telomerase activity and give rise to disease vi Dyskeratosis congenita (DC) is a bone marrow failure syndrome classically associated with a triad of mucocutaneous features: nail dystrophy, oral leukoplakia, and abnormal reticulate skin pigmentation. 1 In contrast to Fanconi anemia, in which a diagnosis can be made on the basis of increased sensitivity of cells to agents that promote chromosomal breakage, 2 no definitive laboratory test is available for DC Dyskeratosis congenita is a rare telomere biology disorder, which results in different clinical manifestations, including severe bone marrow failure Dyskeratosis congenita (DC) was originally defined as a rare inherited bone marrow failure (BMF) syndrome associated with distinct mucocutaneous features. Today DC is defined by its pathogenetic mechanism and mutations in components of the telomere maintenance machinery resulting in excessively short telomeres in highly proliferating tissues

Dyskeratosis Congenita - PubMe

Dyskeratosis congenita is a cancer-prone bone marrow failure syndrome caused by aberrations in telomere biology. We studied 65 patients with dyskeratosis congenita and 127 unaffected relatives Hoyeraal-Hreidasson syndrome) is a very rare multisystem X-linked recessive disorder characterized by excessively short telomeres and is considered a severe form of dyskeratosis congenita. Being an X-linked disorder, Hoyeraal-Hreidasson syndrome primarily affects males. Patients typically present in early childhood with cerebellar hypoplasia, immunodeficiency, progressive bone marrow. The progressive bone marrow failure syndrome dyskeratosis congenita (DC) is often caused by mutations in telomerase or the factors involved in telomerase biogenesis and trafficking. However, a subset of DC patients is heterozygous for mutations in the shelterin component TIN2

Dyskeratosis congenita (DC) is a rare heritable bone marrow failure syndrome that is associated with telomere dysfunction, and has high genetic heterogeneity and varied features. Objective This study aimed to identify the underlying genetic etiology of a DC family with more severe symptoms in the younger generation and to explore the relationship between the genetic causes and the severity of. Dyskeratosis congenita, Zinsser-Cole-Engman syndrome, Congenital dyskeratosis, Cole-Engmann-Zinsser syndrome, MIM 305000, MIM 613989, MIM 615190. Authoritative facts from DermNet New Zealand Mar 17, 2017 - Explore Team Telomere, Inc.'s board Dyskeratosis Congenita, telomere biology disorder, followed by 137 people on Pinterest. See more ideas about telomeres, biology, aplastic anemia Keywords. telomere; telomerase; telomeropathy; TIN2; shelterin; dyskeratosis congenita; The telomeropathies are diseases caused by defective telomeres and have a broad clinical spectrum that ranges from rare inherited syndromes with early onset and severe manifestations such as dyskeratosis congenita (DC), Hoyeraal-Hreidarrson syndrome (HHS), Revesz syndrome (RS), and Coats' plus to more. Patients with dyskeratosis congenita (DC), a disorder of telomere maintenance, suffer degeneration of multiple tissues. Patient-specific induced pluripotent stem (iPS) cells represent invaluable in vitro models for human degenerative disorders like DC

The most widely recognized telomere biology disorder is known as dyskeratosis congenita (DC); others include Hoyeraal-Hreidarsson syndrome, Revesz syndrome, and Coats plus. Key findings: Sixteen patients who experienced GI hemorrhage were identified at 11 centers. Ten patients had a history of hematopoietic cell transplantation Telomere length shows very low telomere length in all populations analyzed (<1% percentile as expected for her given age) and genetic analysis revealed a TERC mutation. Overall this is consistent with Dyskeratosis Congenita

The only long-term, curative treatment option for bone marrow failure in dyskeratosis congenita (DKC) patients is hematopoietic stem cell transplantation (SCT), although long-term outcomes remain.. The Invitae Dyskeratosis Congenita Panel analyzes genes associated with dyskeratosis congenita (DC). DC is a clinically and genetically heterogeneous telomere disorder characterized by abnormal skin pigmentation, nail dystrophy, oral leukoplakia and increased risk of progressive bone marrow failure and malignancies

Background Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterised by dystrophic nails, abnormal skin pigmentation and oral leukoplakia. Patients are at very high risk of cancer and other medical problems. They have exceedingly short telomeres for their age and approximately 60% have a germline mutation in a gene important in telomere biology ( DKC1 , TERC , TERT. Dyskeratosis congenita (DC) is a rare multisystem bone marrow failure syndrome that displays marked clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms of the disease are recognized. The gene that is mutated in the X-linked form of the disease is DKC1. The DKC1 -encoded protein, dyskerin, is a component of small nucleolar ribonucleoprotein. Dyskeratosis congenita Die Dyskeratosis congenita (DC, DKC, Zinsser-Cole-Engman-Syndrom) ist eine mehrere Organsysteme betreffende Erbkrankheit, die sich typischerweise an Haut und Schleimhäuten mit den Symptomen abnorme Hautpigmentierung, Nageldystrophie und Leukoplakie zeigt Dyskeratosis congenita: molecular insights into telomerase function, ageing and cancer - Volume 6 Issue 26 - Anna Marrone, Inderjeet Dokal Skip to main content Accessibility help We use cookies to distinguish you from other users and to provide you with a better experience on our websites Dyskeratosis congenita (DC) is a general term utilized for a variety of genetic disorders whose most characteristic symptoms are excess skin pigmentation, nail dystrophy and mucosal leukoplakia. Disease progress often consists in malignant degeneration of precancerous mucosal lesions , development of squamous cell carcinoma , pulmonary fibrosis or lung cancer [1]

Engineered telomere degradation models dyskeratosis congenit

Updates on the biology and management of dyskeratosis

In contrast, mutation of dyskerin (DKC1; 300126) in X-linked dyskeratosis congenita severely impairs telomerase activity by blocking telomerase assembly and disrupts telomere elongation during reprogramming Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome caused by mutations in seven genes involved in telomere biology, with approximately 50% of cases remaining genetically uncharacterized

Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita Hemanth Tummala, 1 Amanda Walne, 1 Laura Collopy, 1 Shirleny Cardoso, 1 Josu de la Fuente, 2 Sarah Lawson, 3 James Powell, 4 Nicola Cooper, 5 Alison Foster, 5 Shehla Mohammed, 6 Vincent Plagnol, 7 Thomas Vulliamy, 1 and Inderjeet Dokal Khincha PP, Bertuch AA, Agarwal S, Townsley DM, Young NS, Keel S, Shimamura A, Boulad F, Simoneau T, Justino H, Kuo C, Artandi S, McCaslin C, Cox DW, Chaffee S, Collins BF, Giri N, Alter BP, Raghu G, Savage SA (2017) Pulmonary arteriovenous malformations: an uncharacterised phenotype of dyskeratosis congenita and related telomere biology disorders Dyskeratosis congenita (DC) is a multi system bone marrow failure syndrome characterized by muco-cutaneous abnormalities and an increased predisposition to malignancy. It exhibits considerable clinical and genetic heterogeneity. X-linked recessive, autosomal dominant and autosomal recessive forms of the disease are recognized Dyskeratosis congenita affects many parts of the body. Three features are especially characteristic of this disorder: (1) fingernails and toenails that grow poorly or are abnormally shaped; (2) changes in skin coloring (pigmentation), especially on the neck and chest, that resembles the appearance of lace; and (3) white patches inside the mouth (oral leukoplakia) Dyskeratosis congenita (DC) is a rare telomere biology disorder, which results in different clinical manifestations, including severe bone marrow failure. To date, the only curative treatment for the bone marrow failure in DC patients is allogeneic hematopoietic stem cell transplantation. However, due to the toxicity associated to this treatment, improved therapies are recommended for DC patients

Decreased dyskerin levels as a mechanism of telomereCells | Free Full-Text | Dyskerin Mutations Present in

Dyskeratosis Congenita - NORD (National Organization for

Dyskeratosis congenita: new clinical and molecular insights into ribosome function. McGrath JA: Lancet. 1999 ; 353 (9160) : 1204-1205. PMID 10217077 : A telomerase component is defective in the human disease dyskeratosis congenita. Mitchell JR, Wood E, Collins K: Nature. 1999 ; 402 (6761) : 551-555. PMID 1059121 In: Dyskeratosis Congenita and Telomere Biology Disorders: Diagnosis and Management Guidelines, 1st edition, Savage SA, Cook EF (Eds), Dyskeratosis Congenita Outreach, Inc, 2015. Silhan LL, Shah PD, Chambers DC, et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis

Dyskeratosis congenita telomere length testing RepeatD

Dyskeratosis congenita (DC) is a premature ageing syndrome characterised by short telomeres. An X-linked form of DC is caused by mutations in DKC1 which encodes dyskerin, a telomerase component that is essential for telomerase RNA stability. However, mutations in DKC1 are identifiable in only half of X-linked DC families. A four generation family with pulmonary fibrosis and features of DC was. of dyskeratosis congenita (DC), a telomere biology disorder (TBD) and inherited bone marrow failure syndrome caused by germline mutations in telomere maintenance genes resulting in very short telomeres. Baseline pulmonary function tests (PFTs) and long-term clinical outcomes have not been thoroughly studied in DC/TBDs X-linked dyskeratosis congenita is caused by mutations in the DKC1 gene which encodes the protein dyskerin (also known as NAP57 and Cbf5p) , a highly conserved essential nucleolar protein required for telomerase RNA (TR) stability, telomerase activity and telomere maintenance (5, 14)

Team Telomere A Community for Telomere Biology Disorders

Dyskeratosis Congenita (DKC) is a systemic disorder caused by mutations resulting in impaired telomere maintenance. Clinical features include bone marrow failure and an increased risk of developing hematological malignancies Telomere Biology Disorders with Bone Marrow Failure (including Dyskeratosis Congenita) Phase. IND. Telomere Biology Disorders with Bone Marrow Failure (including Dyskeratosis Congenita) Vaccines; Candidates: Indication: Research: Pre-IND: IND: Phase I/II: Phase III: Registration: EXG-5003. COVID-19. Phase. IND. COVID-19: Chromosome Diseases. cell-derived dyskeratosis congenita (DC) organotypic model, Woo and colleagues show that telomere shortening triggers abrogation of canonical Wnt signaling, resulting in defects in intestinal stem cell function.Restoringtelomerecappingand enhancing Wnt signaling can restore the Wnt-telomere feedback loop and rescue DC-associated intestinal.

A telomerase component is defective in the human disease

Dyskeratosis congenita (DC) is a bone marrow failure and cancer predisposition syndrome. Patients with DC have a particularly high risk of developing acute myeloid leukemia and tongue cancer in comparison to the general population, 200 and 1100 fold respectively Dyskeratosis congenita is a rare disorder that often leads to early death owing to a variety of complications and associated disorders. Early diagnosis and intervention is important in care for patients affected by this disease Dyskeratosis congenita, autosomal dominant 2 | Dyskeratosis congenita, autosomal recessive 4 | Leukemia, acute myeloid | Melanoma, cutaneous malignant, 9 | Pulmonary fibrosis and/or bone marrow failure, telomere-related,

dyskeratosis congenita telomere maintenance short age-adjusted telomere telomere length maintenance prominent mucocutaneous abnormality dc encode protein great advance posttranslational modification clinical feature current knowledge recent report proliferative barrier spliceosomal rna aca-ribonucleoprotein enzyme rare inherited bone marrow. Through education, we aim to raise awareness of Dyskeratosis Congenita and telomere repair defects and their management amongst medical professionals, patients and the public. Support. We provide support, coordination and advice for people affected by Dyskeratosis Congenita and telomere repair defects Explanation of issue: Bad grammar; formatting issues; two clinically utilized methods of Dyskeratosis Congenita diagnosis currently not mentioned References supporting change: Alter BP, Baerlocher GM, Savage SA, et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome associated with abnormalities of the skin, fingernails, and tongue. Other clinical manifestations may include epiphora, lung fibrosis, liver cirrhosis, osteoporosis, and a predisposition to develop a variety of malignancies

Dyskeratosis congenita: MedlinePlus Genetic

Dyskeratosis Congenita Boston Children's Hospita

Dyskeratosis congenita (DKC) is a genetically heterogeneous multisystemic disorder caused by defective telomerase maintenance. Clinical findings include increased risk for bone marrow failure, malignancies, and pulmonary and hepatic fibrosis. Other typical findings are dysplastic nails, abnormal pigmentation, and oral leukoplakia Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita. J Allergy Clin Immunol. 2012; 129(2):473-82, 482.e1-3 (ISSN: 1097-6825 Dyskeratosis congenita is a general term for genetic disorders that lead to excess skin pigmentation, nail dystrophy and mucosal leukoplakia. Patients suffer and may die from distinct grades of bone marrow failure. Dyskeratosis Congenita (DC): Read more about Symptoms, Diagnosis, Treatment, Complications, Causes and Prognosis

Savage SA et al, TINF2, a Component of the Shelterin Telomere Protection Complex, Is Mutated in Dyskeratosis Congenita. 2008, The American Journal of Human Genetics 82:501-509. Vulliamy et al., Differences in Disease Severity but Similar Telomere Lengths in Genetic Subgroups of Patients with Telomerase and Shelterin Mutations. 2011 Dyskeratosis congenita (DC) is an inherited bone marrow failure syndrome characterized clinically by the triad of abnormal nails, reticular skin pigmentation, and oral leukoplakia, and is associated with high risk of developing aplastic anemia, myelodysplastic syndrome, leukemia, and solid tumors

Dyskeratosis congenita (DC) is a telomere biology disorder that results from mutations in genes involved in the maintenance of telomere homeostasis i Dyskeratosis Congenita Outreach, Inc. is a 501 (c)(3) grassroots, volunteer-operated foundation serving patients and families affected with Dyskeratosis Congenita & Telomere Biology Disorders. Our mission is to provide information & support services to families worldwide affected by Dyskeratosis Congenita & Telomere Biology Disorders, to encourage the medical community's research in finding. Dyskeratosis congenita as a disorder of telomere maintenanc

TELOMERE - JAX-資訊中心-Info CenterSyndromes Associated with Telomere Shortening | IntechOpenFULL TEXT - Dyskeratosis congenita with leukoplakia: TheBeginning at the ends: telomeres and human disease

Enhancing a Wnt-Telomere Feedback Loop Restores Intestinal

Die Dyskeratosis congenita (DC, DKC, Zinsser-Cole-Engman-Syndrom) ist eine mehrere Organsysteme betreffende Erbkrankheit, die sich typischerweise an Haut und Schleimhäuten mit den Symptomen abnorme Hautpigmentierung, Nageldystrophie und Leukoplakie zeigt.. Die Dyskeratosis congenita ist klinisch und genetisch sehr heterogen.Die Symptome treten meist bereits im Kindesalter auf, das Alter bei. Dyskeratosis congenita (DC) is a bone marrow failure (BMF) syndrome characterized by genetic mutations in the telomere complex. In its classic presentation, DC is a diagnosis based on clinical findings, although the onset of clinical findings may be highly variable Dyskeratosis congenita (DC) is characterized by multiple anomalies including abnormal skin pigmentation, nail dystrophy, mucosal leukoplakia, bone marrow failure and an increase in cancer predisposition (Walne et al. 2007. PubMed ID: 17507419; Kirwan et al. 2008. PubMed ID: 18005359). Individuals affected with DC can exhibit other features including liver cirrhosis, osteoporosis, pulmonary. Dyskeratosis Congenita (DC) is a cancer-prone inherited bone marrow failure syndrome (IBMFS) caused by aberrant telomere biology. DCEG investigators in the Clinical Genetics Branch (CGB) showed that telomere length, as measured by flow cytometry-FISH was both sensitive and specific for distinguishing DC from healthy individuals and from those with other IBMFS Dyskeratosis congenita (DC) is a premature ageing syndrome characterised by short telomeres. An X-linked form of DC is caused by mutations in DKC1 which encodes Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita

  • Pistole ráže 45.
  • Torka korn.
  • Uni Bonn Mail.
  • Cheap rent Malta.
  • Sköna pumps.
  • Konvertibel avtal.
  • Dricker mest whisky i världen.
  • Medeltidsmuseet evenemang.
  • Vega 56 vs 1660 Ti.
  • Hur ser ringorm ut på hund.
  • Honungsglaserad kotlettrad.
  • Joe cole imdb.
  • CS:GO can t connect to official servers.
  • Näsa rita.
  • HSLF FS 2017 8.
  • Minijob Bonn.
  • Mad Max 2021.
  • Couchtuner one.
  • Petri restaurang.
  • Planhyvlad ek 10mm.
  • Cybergymnasiet schema.
  • Blackmagic design ltd.
  • Under Armour löparskor test.
  • Conan the Adventurer.
  • Skillnad mellan psykiatri och socialpsykiatri.
  • JAS 39 Gripen E news.
  • Villa Merlo.
  • Staccato musik.
  • Blackamoor earrings.
  • Biggest first week album sales.
  • Air Port.
  • Evulsio betyder.
  • GSM.
  • Confessions of a Shopaholic book.
  • Reserverat belopp hur länge Swedbank.
  • Min Hyo rin Instagram.
  • Erik Johan Stagnelius.
  • Acne Mohair.
  • Krakatoa facts.
  • Crystal oscillator frequency.
  • Quokka fiender.